CIK 0001768224 · Accelerated filer<br>Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 8589002660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 4 Open-market buy Director bought 2,300 shares at $10.58 ($24,334)
- 8-K Event Other events
- 4 Open-market buy See Remarks bought 500 shares at $10.69 ($5,347)
- 4 Open-market buy President and CEO bought 5,000 shares at $11.22 ($56,100)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $10.90 ($109,000)
- 4 Open-market buy Director bought 9,113 shares at an average $10.94 ($99,672)
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- EFFECT Other Notice of Effectiveness
- 8-K Event Material agreement · Agreement ended
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 20 of 21 · 416 filings